Target intelligence / Profile preview

Ceramide 6-II (Ceramide AP)

Target
Ceramide AP
Molecular classification
Lipid, Sphingolipid, Ceramide, Other
01

Overview

Ceramide 6-II, also known as Ceramide AP, is a specific sphingolipid found in the stratum corneum of the human skin, consisting of an alpha-hydroxy fatty acid linked to a phytosphingosine base (Motta et al., 1993, Biochim Biophys Acta). It plays a crucial role in maintaining the skin's permeability barrier and regulating transepidermal water loss (TEWL) (Coderch et al., 2003, Am J Clin Dermatol). In dermatological conditions such as atopic dermatitis and psoriasis, the levels of Ceramide 6-II are often significantly reduced, leading to impaired barrier function and increased skin sensitivity (PMID: 12558444). While not a traditional protein target like a receptor or enzyme, it is a key therapeutic component in topical formulations designed to restore the lipid barrier and treat inflammatory skin disorders (PubChem). Its primary function is structural, contributing to the lamellar phases that prevent dehydration and protect against environmental pathogens. Therapeutic intervention typically involves the topical application of ceramide-dominant mixtures to replenish the depleted lipid pool (NIH). This approach helps to normalize the skin's physiological state and reduce the need for topical corticosteroids in chronic conditions.

Other names
Ceramide APalpha-hydroxy-N-stearoylphytosphingosineN-(2-hydroxyoctadecanoyl)phytosphingosineCeramide 6Ceramide 6IIPhytosphingosine-type ceramide
02

Mechanism of action

Exogenous replenishment of the stratum corneum lipid matrix to restore barrier function and reduce transepidermal water loss.

03

Biological functions

Skin barrier maintenanceRegulation of transepidermal water lossLipid lamellar organizationOther
04

Disease associations

Atopic dermatitisPsoriasisXerosisIchthyosisInflammationOther
05

Safety considerations

Minimal systemic absorptionPotential for localized skin irritationAllergic reaction to formulation excipients
06

Interacting drugs

EpiCeram

3 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Stratum corneum ceramide levelsSkin hydration levels

Beyond the preview

Go deeper on Ceramide 6-II (Ceramide AP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceramide 6-II (Ceramide AP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call